HALOZYME REPORTS THIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS

Go back to HALOZYME REPORTS THIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 74.97 -0.08 (0.11%)
Previous Close $75.05    52 Week High $18.39 
Open $74.62    52 Week Low $6.96 
Day High $75.09    P/E N/A 
Day Low $73.89    EPS $-0.58 
Volume 94,427